Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glyceraldehyde-3-phosphate dehydrogenase pseudogene 71 (GAPDHP71) is a processed pseudogene, meaning it originated as a reverse-transcribed copy of the parental GAPDH gene and was integrated into the genome. Like most pseudogenes, it has lost the ability to encode a functional protein due to mutations and absent regulatory sequences. GAPDHP71 is cataloged under human gene identifiers (HGNC:4149, NCBI Gene:2613, Ensembl:ENSG00000213376) and is not associated with any known function, disease process, or drug interaction. While some pseudogenes in general can play a role in gene regulation or disease, such effects are not described for GAPDHP71 specifically.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glyceraldehyde-3-phosphate dehydrogenase pseudogene 71 (GAPDHP71).